| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |